RECRUITING

Lymphatic System Stimulation in Heart Failure

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this pilot clinical trial is to obtain preliminary data on the effects of lymphatic exercise training in patients with heart failure. The main question\[s\] it aims to answer are: 1. Does performing lymphatic exercise decrease fluid overload symptoms (shortness of breath, lower legs swelling, fatigue), thoracic fluid content, and body fluid level? 2. Does performing lymphatic exercise improve sleep and quality of life (QOL)? Participants with heart failure will be randomly assigned into two groups: Group 1 will receive training on lymphatic exercises, and will perform these training for 4 weeks. This group will also be trained to monitor daily their weight, heart rate and blood pressure, and fluid overload symptoms. Group 2 will be trained to daily monitor their weight, heart rate and blood pressure, and fluid overload symptoms. This group will not perform the lymphatic exercises. Researchers will compare the two groups at the baseline and after delivering the 4 week-interventions to see 1. if lymphatic exercise helped decrease symptoms associated with fluid overload like shortness of breath, lower leg swelling, and fatigue. 2. if lymphatic exercises decreased thoracic fluid content and total body fluid level . 3. if the lymphatic exercise helped improve sleep and quality of life (QOL).

Official Title

Lymphatic System Stimulation and Fluid Overload Symptoms in Patients With Heart Failure

Quick Facts

Study Start:2023-06-15
Study Completion:2025-10
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05834400

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 80 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Clinical diagnosis of HF with New York Heart Association (NYHA) functional class II, III, or IV
  2. * Willing and able to complete the home-based TOLF program upon discharge from the hospital to home
  1. * Severe liver or kidney insufficiency or malignant tumors
  2. * A terminal condition with a life expectancy of \< 6 months
  3. * Received or waiting for heart transplantation
  4. * Pregnancy
  5. * Cognitive impairment (e.g., dementia)
  6. * Severe psychiatric condition (psychotic disorder, severe depression, suicidal intent)
  7. * Inability to converse in English

Contacts and Locations

Study Contact

Rida Gharzeddine, PhD
CONTACT
2016570912
rg1041@rutgers.edu
Elizabeth Cerceo, MD
CONTACT
856-577-8975
cerceo-elizabeth@cooperhealth.edu

Principal Investigator

Rida Gharzeddine, PhD
PRINCIPAL_INVESTIGATOR
Rutgers, The State University of New Jersery

Study Locations (Sites)

Cooper University Health Care (Cooper)
Camden, New Jersey, 08103
United States

Collaborators and Investigators

Sponsor: Rutgers, The State University of New Jersey

  • Rida Gharzeddine, PhD, PRINCIPAL_INVESTIGATOR, Rutgers, The State University of New Jersery

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-15
Study Completion Date2025-10

Study Record Updates

Study Start Date2023-06-15
Study Completion Date2025-10

Terms related to this study

Keywords Provided by Researchers

  • Heart failure
  • Cardiac Edema
  • Self-care
  • Exercise Movement Techniques

Additional Relevant MeSH Terms

  • Heart Failure